Business

First patient treated in the UK for the TRIPP-FXX study

First patient treated in the UK for the TRIPP-FXX study

Oncosil Medical LtdApril 11, 20245

First patient treated in the UK for the TRIPP-FXX study

About this update from Oncosil Medical Ltd

Oncosil Medical Ltd has released a press release. View Attachment

View stock analysis, news, and events for Oncosil Medical Ltd

More from Oncosil Medical Ltd

OSL Secures $5.6 million from Major Institutional Investors

September 7, 2026

OncoSil Receives FDA Approval for Distal Cholangiocarcinoma

August 16, 2026

All Oncosil Medical Ltd news →